{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:01:30Z","timestamp":1774123290361,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.jinf.2005.01.001","type":"journal-article","created":{"date-parts":[[2005,3,3]],"date-time":"2005-03-03T07:54:01Z","timestamp":1109836441000},"page":"e177-e180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["A case of disseminated histoplasmosis successfully treated with the investigational drug posaconazole"],"prefix":"10.1016","volume":"51","author":[{"given":"B.","family":"Clark","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tunbridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2005.01.001_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0891-5520(02)00039-9","article-title":"Histoplasmosis","volume":"17","author":"Wheat","year":"2003","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jinf.2005.01.001_bib2","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1086\/313752","article-title":"Practice guidelines for the management of patients with histoplasmosis: Infectious Diseases Society of America","volume":"30","author":"Wheat","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2005.01.001_bib3","series-title":"Principles and practice of infectious diseases","first-page":"2718","article-title":"Histoplasma capsulatum","author":"Deepe","year":"2000"},{"key":"10.1016\/j.jinf.2005.01.001_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/00365540050165901","article-title":"Imported and autochthonous histoplasmosis in Bergamo province, Northern Italy","volume":"32","author":"Farina","year":"2000","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2005.01.001_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1468-1293.2003.00144.x","article-title":"Disseminated histoplasmosis with atypical cutaneous lesions in an Italian HIV-infected patient: another autochtomous case","volume":"4","author":"Calza","year":"2003","journal-title":"HIV Med"},{"key":"10.1016\/j.jinf.2005.01.001_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2310\/7060.2000.00028","article-title":"Imported histoplasmosis in Spain","volume":"7","author":"Gascon","year":"2000","journal-title":"J Travel Med"},{"key":"10.1016\/j.jinf.2005.01.001_bib7","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1086\/344061","article-title":"Fungal infections among returning travellers","volume":"35","author":"Panackal","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2005.01.001_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1053\/srin.2001.24241","article-title":"The epidemiology of histoplasmosis: a review","volume":"16","author":"Cano","year":"2001","journal-title":"Semin Respir Infect"},{"key":"10.1016\/j.jinf.2005.01.001_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1055\/s-2007-1012698","article-title":"Histoplasmosis","volume":"9","author":"Johnson","year":"1987","journal-title":"Semin Respir Med"},{"key":"10.1016\/j.jinf.2005.01.001_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/jac\/43.2.267","article-title":"Risk factors for amphotericin B-induced nephrotoxicity","volume":"43","author":"Luber","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2005.01.001_bib11","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0002-9343(01)00928-7","article-title":"The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy","volume":"111","author":"Harbarth","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.jinf.2005.01.001_bib12","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1128\/JCM.36.10.2950-2956.1998","article-title":"Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts","volume":"36","author":"Espinel-Ingroff","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2005.01.001_bib13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1128\/AAC.43.2.322","article-title":"Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice","volume":"43","author":"Connolly","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2005.01.001_bib14","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1128\/AAC.44.10.2604-2608.2000","article-title":"Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice","volume":"44","author":"Connolly","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2005.01.001_bib15","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.tim.2003.08.007","article-title":"Current diagnosis of histoplasmosis","volume":"11","author":"Wheat","year":"2003","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.jinf.2005.01.001_bib16","doi-asserted-by":"crossref","unstructured":"Courtney R, Sansone A, Smith W, et al. Posaconazole pharmacokinetics, safety, and tolerability in subjects with varying degrees of chronic renal disease. J Clin Pharmacol 2005;45:198\u201392.","DOI":"10.1177\/0091270004271402"},{"key":"10.1016\/j.jinf.2005.01.001_bib17","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1128\/AAC.48.9.3543-3551.2004","article-title":"Disposition of posaconazole following single-dose oral administration in healthy subjects","volume":"48","author":"Krieter","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2005.01.001_bib18","unstructured":"Greenberg RN. Posaconazole therapy for refractory invasive zygomycosis. Poster presented at: 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Abstract M-1757. Chicago, IL; September 14\u201317, 2003."},{"key":"10.1016\/j.jinf.2005.01.001_bib19","unstructured":"Ullmann AJ, Cornely OA, Burchardt A, et al. Safety and efficacy of posaconazole (POS) in a pharmacokinetic study in patients with febrile neutropenia (FN) or refractory invasive fungal infections (rIFI). Poster presented at: 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Abstract M-1257. Chicago, IL; September 14\u201317, 2003."}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445305000022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445305000022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:28:58Z","timestamp":1758986938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445305000022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0163445305000022"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2005.01.001","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of disseminated histoplasmosis successfully treated with the investigational drug posaconazole","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2005.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}